# Probiotics Skin Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/probiotics-skin-randomized-trial-evidence-review
Category: evidence-review
Summary: Probiotics Skin Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed 
Last reviewed: 2026-06-02
Reviewed by: Migaku Evidence Review
# Probiotics Skin Randomized Trial: What the Evidence Says

## Quick Answer

Probiotics Skin Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions | preclinical study | 4 | 2026-04-16 | 10.1111/srt.70352 |
| The Role of Biotics in Rosacea: A Narrative Review | preclinical study | 4 | 2026-03-24 | 10.7759/cureus.105799 |

## What The Sources Report

- Elevated reactive oxygen species (ROS) also play a key role, as increased ROS levels are found in patients with rosacea. [Muacevic Alexander (2026); evidence level 4]
- Mendelian randomization studies have linked certain bacterial taxa, including uncategorized andspecies, to an increased risk of rosacea, while other taxa appear to confer a protective effect. [Muacevic Alexander (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For probiotics skin randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Taléns‐Visconti Raquel (2026). Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions. DOI: 10.1111/srt.70352. PMCID: PMC13084527. PMID: 41988834. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13084527/
- Muacevic Alexander (2026). The Role of Biotics in Rosacea: A Narrative Review. DOI: 10.7759/cureus.105799. PMCID: PMC13106664. PMID: 42037847. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13106664/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.